Recalls of prescription drugs, over-the-counter medications, and compounded pharmaceuticals.
Showing 201–220 of 1,000 recalls
OMEZA LLC
CGMP Deviations
Bestco LLC
CGMP Deviations: Potential Glass and Silicone particulates in product
Amneal Pharmaceuticals of New York, LLC
Failed Impurities/Degradation Specifications: Out of specification for unknown impurity.
Golden State Medical Supply Inc.
Failed Dissolution Specifications
Amerisource Health Services LLC
Failed Impurities/Degradation Specification.
BE PHARMACEUTICALS AG
Lack of Sterility Assurance: Aseptic process simulation failure.
Lupin Pharmaceuticals Inc.
Subpotent Drug and Failed Impurities/Degradation Specifications
Azurity Pharmaceuticals, Inc.
Labeling: Label Mix-up
Glenmark Pharmaceuticals Inc., USA
Failed Excipient Specifications: OOS for assay of Isopropyl Alcohol
Failed Impurities/Degradation Specifications
Strides Pharma Inc.
Haleon US Holdings LLC
Microbial Contamination of Non-Sterile Products
Failed dissolution specifications
CGMP Deviations: N-Nitroso Desloratadine impurity result exceeded the acceptable intake limit.
Dr. Reddy's Laboratories, Inc.
Presence of Foreign Tablets/Capsules: One 0.5 mg Tacrolimus capsule found in a bottle of 1 mg Tacrolimus capsules.
GlaxoSmithKline LLC
Failed Release Testing: Coarse Particle Mass for umeclidinium Out of Specification
Failed Impurities/Degradation Specifications: Out of specification Impurity C (4,5-desisopropylidene topiramate) result observed during routine stability testing at 18 months.